BCM
EW icon

Bienville Capital Management’s Edwards Lifesciences EW Stock Holding History

Bienville Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,200
Closed -$280K – 66
2014
Q4 		$280K Buy
+13,200
New +$265K 0.23% 65

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bienville Capital Management's EW Position: Q1 2015 in Review

Bienville Capital Management sold out of Edwards Lifesciences (EW) in Q1 2015, closing a stake of 13,200 shares — an estimated $280K sold.

Bienville Capital Management first reported a position in EW in Q4 2014 and held it in 1 quarter. The position peaked at $280K in Q4 2014. 575 funds tracked by Wall St. Rank hold EW as of Q1 2015.

  • Bienville Capital Management reported no remaining Edwards Lifesciences position as of Q1 2015 after selling out during the quarter.
  • Bienville Capital Management sold 13,200 Edwards Lifesciences shares in Q1 2015, an estimated $280K.
  • Bienville Capital Management first reported a position in Edwards Lifesciences in Q4 2014 and held it in 1 quarter.
  • Bienville Capital Management's Edwards Lifesciences position peaked at $280K in Q4 2014.
  • 575 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on Bienville Capital Management's 13F filing for Q1 2015, filed 13 May 2015.